Fundraising FoxArkin Capital — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Entact is a drug discovery company developing treatments for patients.
BiotechDeep TechWatertown, US
Victoria Richon(Executive Officer, Director, Promoter)inRuben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)
BoardAndrew Sinclair(Director)Anna French(Director)in
Co-investorsvenBio PartnersAbingworthQiming Venture PartnersvenBio Global Strategic
Boston-area biotech developing gene therapies for genetic causes of pediatric hearing loss.
BiotechCambridge, US
Giampiero De Luca(Director)Jodi A. Cook(Executive Officer, Director)Will McLean(Executive Officer)
BoardSteve Gillis(Director)in
Co-investorsARCH Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.